Header Logo

Connection

Gabriel Pardo to Natalizumab

Back to Details
This is a "connection" page, showing publications Gabriel Pardo has written about Natalizumab.
Gabriel Pardo
Connection Strength
0.029
Natalizumab
  1. Natalizumab treatment shows no clinically meaningful effects on immunization responses in patients with relapsing-remitting multiple sclerosis. J Neurol Sci. 2014 Jun 15; 341(1-2):22-7.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.